Company Regnum Pharma S.r.l. with Fiscal Code 41325824
recorded a turnover of 2024 of
2.924.204,
with a net profit of
97.857
and having an average number of employees of
12.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Regnum Pharma S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
-
-
596.219
2.856.017
2.857.431
2.934.835
2.614.886
2.924.204
Total Income - EUR
-
-
-
-
596.640
2.861.882
2.859.848
2.936.599
2.632.381
2.924.270
Total Expenses - EUR
-
-
-
-
620.755
2.861.978
2.813.655
2.903.807
2.708.705
2.818.321
Gross Profit/Loss - EUR
-
-
-
-
-24.116
-96
46.194
32.792
-76.324
105.949
Net Profit/Loss - EUR
-
-
-
-
-24.116
-96
41.842
26.727
-76.324
97.857
Employees
-
-
-
-
2
5
4
5
7
12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.5%, from 2.614.886 euro in the year 2023, to 2.924.204 euro in 2024.
The Net Profit increased by 97.857 euro, from 0 euro in 2023, to 97.857 in the last year.
Check the financial reports for the company - Regnum Pharma S.r.l.
Financial Rating - REGNUM PHARMA S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Regnum Pharma S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Regnum Pharma S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Regnum Pharma S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Regnum Pharma S.r.l. - CUI 41325824
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
-
-
659
1.311
33.273
97.739
121.783
134.559
Current Assets
-
-
-
-
199.738
171.944
137.108
322.616
606.543
775.175
Inventories
-
-
-
-
101.186
90.776
21.154
117.787
138.823
147.042
Receivables
-
-
-
-
93.174
45.274
62.913
134.676
378.819
579.101
Cash
-
-
-
-
5.378
35.894
53.041
70.153
88.901
49.032
Shareholders Funds
-
-
-
-
-14.633
-14.452
27.711
34.931
-68.146
22.987
Social Capital
-
-
-
-
9.483
9.303
9.097
9.125
9.097
9.046
Debts
-
-
-
-
215.742
188.846
144.560
386.895
798.007
889.431
Income in Advance
-
-
-
-
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
775.175 euro in 2024 which includes Inventories of
147.042 euro, Receivables of
579.101 euro and cash availability of
49.032 euro.
The company's Equity was valued at
22.987 euro, while total Liabilities amounted to
889.431 euro.
Equity increased by 90.752 euro, from -68.146 euro in 2023, to 22.987 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Regnum Pharma S.r.l.